Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema

T. Caballero, A. Sala-Cunill, M. Cancian, Timothy Craig, S. Neri, P. K. Keith, I. Boccon-Gibod, C. Bethune, K. Bork

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Results from a 16-question survey about self-administration of hereditary angioedema (HAE) therapy, administered in Europe, Canada and the USA, were used to guide discussion at an international HAE expert meeting. The aim was to capture information about current practice in self-administered HAE therapy in these countries, including self-administration training, the key benefits of switching to self-administration, the barriers to self-administration and trends in self-administration. Overall, switching to self-administration therapy is looked upon favourably from both patient and clinician perspectives by virtue of the potential improvement in quality of life arising from optimisation of therapy and early intervention. The recent changes to product licences allowing self-administration provide additional options for the management of HAE.

Original languageEnglish (US)
Pages (from-to)10-16
Number of pages7
JournalInternational Archives of Allergy and Immunology
Volume161
DOIs
StatePublished - Jan 1 2013

Fingerprint

Hereditary Angioedemas
Self Administration
Canada
Licensure
Therapeutics
Quality of Life

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Caballero, T. ; Sala-Cunill, A. ; Cancian, M. ; Craig, Timothy ; Neri, S. ; Keith, P. K. ; Boccon-Gibod, I. ; Bethune, C. ; Bork, K. / Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema. In: International Archives of Allergy and Immunology. 2013 ; Vol. 161. pp. 10-16.
@article{4475c8c695b8484faf7b4d6dd99f5e40,
title = "Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema",
abstract = "Results from a 16-question survey about self-administration of hereditary angioedema (HAE) therapy, administered in Europe, Canada and the USA, were used to guide discussion at an international HAE expert meeting. The aim was to capture information about current practice in self-administered HAE therapy in these countries, including self-administration training, the key benefits of switching to self-administration, the barriers to self-administration and trends in self-administration. Overall, switching to self-administration therapy is looked upon favourably from both patient and clinician perspectives by virtue of the potential improvement in quality of life arising from optimisation of therapy and early intervention. The recent changes to product licences allowing self-administration provide additional options for the management of HAE.",
author = "T. Caballero and A. Sala-Cunill and M. Cancian and Timothy Craig and S. Neri and Keith, {P. K.} and I. Boccon-Gibod and C. Bethune and K. Bork",
year = "2013",
month = "1",
day = "1",
doi = "10.1159/000351233",
language = "English (US)",
volume = "161",
pages = "10--16",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",

}

Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema. / Caballero, T.; Sala-Cunill, A.; Cancian, M.; Craig, Timothy; Neri, S.; Keith, P. K.; Boccon-Gibod, I.; Bethune, C.; Bork, K.

In: International Archives of Allergy and Immunology, Vol. 161, 01.01.2013, p. 10-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema

AU - Caballero, T.

AU - Sala-Cunill, A.

AU - Cancian, M.

AU - Craig, Timothy

AU - Neri, S.

AU - Keith, P. K.

AU - Boccon-Gibod, I.

AU - Bethune, C.

AU - Bork, K.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Results from a 16-question survey about self-administration of hereditary angioedema (HAE) therapy, administered in Europe, Canada and the USA, were used to guide discussion at an international HAE expert meeting. The aim was to capture information about current practice in self-administered HAE therapy in these countries, including self-administration training, the key benefits of switching to self-administration, the barriers to self-administration and trends in self-administration. Overall, switching to self-administration therapy is looked upon favourably from both patient and clinician perspectives by virtue of the potential improvement in quality of life arising from optimisation of therapy and early intervention. The recent changes to product licences allowing self-administration provide additional options for the management of HAE.

AB - Results from a 16-question survey about self-administration of hereditary angioedema (HAE) therapy, administered in Europe, Canada and the USA, were used to guide discussion at an international HAE expert meeting. The aim was to capture information about current practice in self-administered HAE therapy in these countries, including self-administration training, the key benefits of switching to self-administration, the barriers to self-administration and trends in self-administration. Overall, switching to self-administration therapy is looked upon favourably from both patient and clinician perspectives by virtue of the potential improvement in quality of life arising from optimisation of therapy and early intervention. The recent changes to product licences allowing self-administration provide additional options for the management of HAE.

UR - http://www.scopus.com/inward/record.url?scp=84878003349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878003349&partnerID=8YFLogxK

U2 - 10.1159/000351233

DO - 10.1159/000351233

M3 - Article

C2 - 23689239

AN - SCOPUS:84878003349

VL - 161

SP - 10

EP - 16

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

ER -